Clinicopathological and Prognostic Implications of Circulating MicroRNA-429 in Breast Cancer Patients.
BACKGROUND/AIMS MicroRNA-429 (miR-429), a member of the miR-200 family, has been implicated in epithelial-mesenchymal transition and tumor progression, yet its clinicopathological significance in breast cancer remains unclear. This study aimed to evaluate serum miR-429 expression in treatment-naïve breast cancer patien...